Rabeprazole sodium and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Rabeprazole sodium (rabeprazole sodium), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Nitroglycerin, and have High blood pressure.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Rabeprazole sodium. It is created by eHealthMe based on reports of 15,623 people who have side effects when taking Rabeprazole sodium from the FDA, and is updated regularly.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,638 drugs and 2,517 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

On Jul, 16, 2026

15,623 people reported to have side effects when taking Rabeprazole sodium.
Among them, 41 people (0.26%) have Urinary incontinence.

Could Rabeprazole sodium cause Urinary incontinence?

Among these 41 people:

How long have people been on Rabeprazole sodium when they have Urinary incontinence? *

What is the gender of people who have Urinary incontinence when taking Rabeprazole sodium? *

female: 48.65 %
male: 51.35 %

What is the age of people who have Urinary incontinence when taking Rabeprazole sodium? *

What are other drugs people take besides Rabeprazole sodium? *

What are other side effects people have besides Urinary incontinence? *

Insomnia (sleeplessness): 26 people, 63.41%
Nausea And Vomiting: 24 people, 58.54%
Pain: 24 people, 58.54%
Weakness: 23 people, 56.10%
Fatigue (feeling of tiredness): 22 people, 53.66%
Confusional State: 21 people, 51.22%
Dyspnea (difficult or laboured breathing): 21 people, 51.22%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 19 people, 46.34%
Chills (felling of cold): 19 people, 46.34%
Fall: 17 people, 41.46%

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 39.02%
Pain: 15 people, 36.59%
Metastases To Bone (cancer spreads to bone): 15 people, 36.59%
Multiple Myeloma (cancer of the plasma cells): 14 people, 34.15%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 14 people, 34.15%
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 14 people, 34.15%
Stress And Anxiety: 14 people, 34.15%
Insomnia (sleeplessness): 14 people, 34.15%
Dysthymia (mild chronic depression): 5 people, 12.20%
Carcinoid Tumor: 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole sodium and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole sodium:

Rabeprazole sodium (15,786 reports)

Browse all side effects of Rabeprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Urinary incontinence (1,638 drugs)

Browse all the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,517 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole sodium) and Rabeprazole sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.